Buy Rating on Insmed With Increased Price Target Following Successful Phase 3 ASPEN Study of Brensocatib

TipRanks14:55 ET

Kratos Rated Market Outperform at JMP Securities

Seeking Alpha14:51 ET

ONE Gas Analyst Ratings

Benzinga13:45 ET

Spire Analyst Ratings

Benzinga13:41 ET

Morgan Stanley Maintains Equal-Weight on Spire, Raises Price Target to $67

Benzinga13:42 ET

MGE Energy Analyst Ratings

Benzinga13:34 ET

Illinois' New Tiered Tax System Spells Competitive Advantage for Rush Street Interactive: A Buy Rating Analysis

TipRanks13:25 ET

Kronos Worldwide Analyst Ratings

Benzinga13:14 ET

Insmed Analyst Ratings

Benzinga13:05 ET

Truist Securities Raises Price Target on E.l.f. Beauty to $210 From $200, Maintains Buy Rating

MT Newswires13:02 ET

Assertio Holdings Analyst Ratings

Benzinga12:59 ET

Cytokinetics Analyst Ratings

Benzinga12:08 ET

Atlanticus Holdings Analyst Ratings

Benzinga12:00 ET

Ventyx Biosciences (VTYX) Receives a Buy From LifeSci Capital

TipRanksMay 28 11:45 ET

PTC Therapeutics Analyst Ratings

BenzingaMay 28 11:45 ET

Goldman Sachs Maintains Sell on PTC Therapeutics, Raises Price Target to $32

BenzingaMay 28 11:46 ET

Stifel Raises FTAI Aviation Price Target to $69 From $66, Maintains Hold Rating

MT NewswiresMay 28 11:44 ET

Erasca Analyst Ratings

BenzingaMay 28 11:38 ET

Goldman Sachs Maintains Buy on Erasca, Lowers Price Target to $4

BenzingaMay 28 11:40 ET

PDF Solutions Analyst Ratings

BenzingaMay 28 11:27 ET